Elekta AB (EKTAY)
6.715
-0.20
(-2.96%)
USD |
OTCM |
Apr 25, 11:49
Elekta Cash from Investing (TTM): -184.19M for Jan. 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -184.19M |
October 31, 2023 | -172.41M |
July 31, 2023 | -148.79M |
April 30, 2023 | -155.27M |
January 31, 2023 | -173.13M |
October 31, 2022 | -172.95M |
July 31, 2022 | -191.79M |
April 30, 2022 | -186.05M |
January 31, 2022 | -163.09M |
October 31, 2021 | -93.60M |
July 31, 2021 | -66.20M |
April 30, 2021 | -70.17M |
January 31, 2021 | -59.44M |
October 31, 2020 | -152.10M |
July 31, 2020 | -155.87M |
April 30, 2020 | -134.98M |
January 31, 2020 | -130.33M |
October 31, 2019 | -82.95M |
July 31, 2019 | -73.97M |
April 30, 2019 | -74.69M |
January 31, 2019 | -85.16M |
October 31, 2018 | -92.04M |
July 31, 2018 | -110.10M |
April 30, 2018 | -115.47M |
January 31, 2018 | -110.40M |
Date | Value |
---|---|
October 31, 2017 | -98.10M |
July 31, 2017 | -91.38M |
April 30, 2017 | -90.75M |
January 31, 2017 | -85.62M |
October 31, 2016 | -94.07M |
July 31, 2016 | -88.29M |
April 30, 2016 | -93.33M |
January 31, 2016 | -128.93M |
October 31, 2015 | -133.53M |
July 31, 2015 | -145.39M |
April 30, 2015 | -154.04M |
January 31, 2015 | -124.88M |
October 31, 2014 | -126.08M |
July 31, 2014 | -125.62M |
April 30, 2014 | -119.15M |
January 31, 2014 | -123.95M |
October 31, 2013 | -119.42M |
July 31, 2013 | -104.91M |
April 30, 2013 | -99.30M |
January 31, 2013 | -101.98M |
October 31, 2012 | -77.92M |
July 31, 2012 | -561.53M |
April 30, 2012 | -545.96M |
January 31, 2012 | -513.49M |
October 31, 2011 | -522.72M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-191.79M
Minimum
Jul 2022
-59.44M
Maximum
Jan 2021
-132.10M
Average
-150.44M
Median
Cash from Investing (TTM) Benchmarks
Abliva AB | -0.0574M |
Karolinska Development AB | -1.887M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | -0.2606M |
Olink Holding AB | -22.43M |